These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4153180)

  • 1. [Clinical effect of salazosulfapyridine (salazopyrin) in Crohn's disease. A controlled double-blind investigation].
    Anthonisen P; Bárány F; Folkenborg O; Holtz A; Jarnum S; Kristensen M; Riis P; Walan A; Worning H
    Ugeskr Laeger; 1974 Aug; 136(32):1798-802. PubMed ID: 4153180
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical effect of salazosulphapyridine (Salazopyrin r) in Crohn's disease. A controlled double-blind study.
    Anthonisen P; Barany F; Folkenborg O; Holtz A; Jarnum S; Kristensen M; Riis P; Walan A; Worning H
    Scand J Gastroenterol; 1974; 9(6):549-54. PubMed ID: 4153646
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result.
    Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O; Rosén A
    Gastroenterology; 1982 Sep; 83(3):550-62. PubMed ID: 6124474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term prophylactic effect of salazosulphapyridine (Salazopyrin) in primarily resected patients with Crohn's disease. A controlled double-blind trial.
    Wenckert A; Kristensen M; Eklund AE; Barany F; Jarnum S; Worning H; Folkenborg O; Holtz A; Bonnevie O; Riis P
    Scand J Gastroenterol; 1978; 13(2):161-7. PubMed ID: 24891
    [No Abstract]   [Full Text] [Related]  

  • 5. [Further controlled studies on the effectiveness of salazosulfapyridine in the treatment of Crohn disease].
    Malchow H
    Z Gastroenterol Verh; 1981 Jun; 19():45-9. PubMed ID: 6168135
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of recurrence by salazosulfapyridine (azulfidine) therapy in Crohn's disease. A double blind study].
    Ewe K; Holtermüller KH; Baas U; Eckhart V; Krieg H; Kutzner J; Schäfer A
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():930-2. PubMed ID: 18856
    [No Abstract]   [Full Text] [Related]  

  • 7. A trial of sulfasalazine as adjunctive therapy in Crohn's disease.
    Singleton JW; Summers RW; Kern F; Becktel JM; Best WR; Hansen RN; Winship DH
    Gastroenterology; 1979 Oct; 77(4 Pt 2):887-97. PubMed ID: 38179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative treatment with corticosteroids and salazosulphapyridine (Salazopyrin) after radical resection for Crohn's disease.
    Bergman L; Krause U
    Scand J Gastroenterol; 1976; 11(7):651-6. PubMed ID: 11545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How should we treat Crohn's disease?
    Sleisenger MH
    N Engl J Med; 1980 May; 302(18):1024-6. PubMed ID: 6102738
    [No Abstract]   [Full Text] [Related]  

  • 10. Azathioprine-related pancreatitis in patients with Crohn's disease.
    Sturdevant RA; Singleton JW; Deren JL; Law DH; McCleery JL
    Gastroenterology; 1979 Oct; 77(4 Pt 2):883-6. PubMed ID: 38178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. I. Design and methodologic considerations.
    Rosén A; Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O
    Gastroenterology; 1982 Sep; 83(3):541-9. PubMed ID: 6124473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Crohn's disease (author's transl)].
    Vrubel F; Martínek K; Vítek J
    Cesk Gastroenterol Vyz; 1974 Jul; 28(5):311-4. PubMed ID: 4152472
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of treatment with sulfasalazine in the American Multicenter Study on the treatment of Crohn disease (National Cooperative Crohn's Disease Study)].
    Singleton JW
    Z Gastroenterol Verh; 1981 Jun; 19():38-40. PubMed ID: 6168133
    [No Abstract]   [Full Text] [Related]  

  • 14. Shortcomings of the National Crohn's Disease Study: the exclusion of azathioprine without adequate trial.
    Korelitz BI; Present DH
    Gastroenterology; 1981 Jan; 80(1):193-6. PubMed ID: 6108892
    [No Abstract]   [Full Text] [Related]  

  • 15. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment.
    Malchow H; Ewe K; Brandes JW; Goebell H; Ehms H; Sommer H; Jesdinsky H
    Gastroenterology; 1984 Feb; 86(2):249-66. PubMed ID: 6140202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The National Cooperative Crohn's Disease Study.
    MacLean LD
    Can J Surg; 1980 Jan; 23(1):7-8. PubMed ID: 6102492
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of Crohn's disease with azathioprine: a controlled evaluation.
    Klein M; Binder HJ; Mitchell M; Aaronson R; Spiro H
    Gastroenterology; 1974 May; 66(5):916-22. PubMed ID: 4597093
    [No Abstract]   [Full Text] [Related]  

  • 18. Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis.
    Steinhart AH; Hemphill D; Greenberg GR
    Am J Gastroenterol; 1994 Dec; 89(12):2116-24. PubMed ID: 7977225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metronidazole in Crohn's disease.
    Gilat T
    Gastroenterology; 1982 Sep; 83(3):702-4. PubMed ID: 6124478
    [No Abstract]   [Full Text] [Related]  

  • 20. [The prophylactic effect of salazosulfapyridine in ulcerative colitis after a period of one year without symptoms on long-term treatment. A double-blind investigation].
    Binder V; Bonnevie O; Folkenborg O; Anthonisen P; Wulff HR; Riis P
    Ugeskr Laeger; 1972 Oct; 134(40):2093-5. PubMed ID: 4405794
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.